Name
Rigel Pharmaceuticals
Company Description
Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing, and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer.
Rigel has 3 FDA approved products:
• TAVALISSE® (fostamatinib disodium hexahydrate) tablets was approved in 2018. Visit www.TAVALISSEhcp.com to learn more.
• GAVRETO® (pralsetinib) capsules was approved in 2020. Visit www.GAVRETO-hcp.com to learn more.
• REZLIDHIA® (olutasidenib) capsules was approved in 2022. Visit www.REZLIDHIAhcp.com to learn more.
Rigel has 3 FDA approved products:
• TAVALISSE® (fostamatinib disodium hexahydrate) tablets was approved in 2018. Visit www.TAVALISSEhcp.com to learn more.
• GAVRETO® (pralsetinib) capsules was approved in 2020. Visit www.GAVRETO-hcp.com to learn more.
• REZLIDHIA® (olutasidenib) capsules was approved in 2022. Visit www.REZLIDHIAhcp.com to learn more.
Website
Featured Exhibitor
Yes
Address
South San Francisco,
United States
United States
Badges
